Skip to main content
Canna~Fangled Abstracts

Endocannabinoids increase human adipose stem cell differentiation and growth factor secretion in vitro

By November 11, 2020January 19th, 2021No Comments
. 2020 Nov 11.

doi: 10.1002/term.3152.

Online ahead of print.
Tim Ruhl 1, Pia-Alina Schneider 1, Bong-Sung Kim 1 2, Justus P Beier 1
Affiliations 

Abstract

Adipose stem cells (ASCs) possess the capacity to proliferate, to differentiate into various cells types, and they are able to secrete growth factors. These characteristics are supposed to contribute to their potential for regenerative medicine approaches. In order to advance the therapeutic effects of ASCs, different modulatory procedures have been examined. In this context, the endocannabinoid system (ECS) represents an interesting possibility, since the increased availability of cannabinoids and the underlying molecular pathways of the ECS are of relevance for the development of new regenerative strategies. The effects of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) were investigated on ASC metabolic activity, quantified by PrestoBlue conversion, and cell numbers, evaluated by crystal violet staining. enzyme-linked immunosorbent assay (ELISA) measures were performed to determine cytokine release, and differentiation was assessed by specific labeling techniques. AEA increased the metabolic activity, while 2-AG decreased it in a concentration dependent manner. AEA significantly enhanced OilRed O staining after adipogenic differentiation by over 100%, and both compounds significantly increased cresolphthalein staining after osteogenic differentiation. By contrast, they did not affect sphere diameter or safranin O staining after chondrogenic differentiation. Both substances significantly increased the release of insulin-like growth factor-1 and hepatocyte growth factor, while only AEA enhanced transforming growth factor-β secretion. The results demonstrated that stimulating the ECS exerted significant effects on the biology of ASCs. Exposure to endocannabinoids modulated viability, induced release of regenerative growth factors, and promoted adipogenic and osteogenic differentiation. Our findings could be of specific relevance in ASC based therapies for regenerative medicine.

 

Keywords: 2‐arachidonoylglycerol, adipose stem cell, anandamide, cytokine, differentiation, proliferation

References

REFERENCES
    1. Ahn, S., Yi, S., Seo, W. J., Lee, M. J., Song, Y. K., Baek, S. Y. … Noh, M. (2015). A cannabinoid receptor agonist N‐arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells. Biomolecules & Therapeutics, 23(3), 218‐224. https://doi.org/10.4062/biomolther.2014.137
    1. Arrowsmith, J., & Miller, P. (2013). Trial watch: Phase II and phase III attrition rates 2011‐2012. Nature Reviews Drug Discovery, 12(8), 569. https://doi.org/10.1038/nrd4090
    1. Bab, I., Ofek, O., Tam, J., Rehnelt, J., & Zimmer, A. (2008). Endocannabinoids and the regulation of bone metabolism. Journal of Neuroendocrinology, 20(Suppl 1), 69–74. https://doi.org/10.1111/j.1365-2826.2008.01675.x
    1. Baggelaar, M. P., Maccarrone, M., & van der Stelt, M. (2018). 2‐Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. Progress in Lipid Research, 71, 1–17. https://doi.org/10.1016/j.plipres.2018.05.002
    1. Behm, B., Babilas, P., Landthaler, M., & Schreml, S. (2012). Cytokines, chemokines and growth factors in wound healing. Journal of the European Academy of Dermatology and Venereology, 26(7), 812–820. https://doi.org/10.1111/j.1468-3083.2011.04415.x

Leave a Reply